The effect of Vitamin D supplementation on patients with secondary hyperparathyroidism and hemodialysis, helps the parathyroid hormone return to its normal set point. The effect of intravenous 1, 25(OH)2D therapy has been shown to increase the parathyroid hormone ( PTH ) secretion (1). The subjects for this experiment were fourteen normal people and 13 patients with undergoing hemodialysis. The hemodialysis patients were then broken down into 6 patients with elevated PTH (EBI) at greater than 10 pmol/L and seven patients …showed first 75 words of 986 total…

…showed last 75 words of 986 total…levels in hemodialysis patients with secondary hyperparathyroidism. The five study showed that the importance of supplementing an active source of vitamin D whether its 1,25(OH)2D, 25(OH),or falecalcitriol helps decrease the serum parathyroid hormones in individuals suffering from secondary hyperparathyroidism and undergoing hemodialysis. The supplementation can be by mouth or intravenously. More care should be followed when giving vitamin D to children due to the fact that it may affect growth and bone problems.